Well Told Grants

Federal grant programs / Allergy and Infectious Diseases Research

Allergy and Infectious Diseases Research in Rhode Island

Allergy and Infectious Diseases Research (93.855) awarded $66.5 million to recipients in Rhode Island in 135 grants from fiscal 2021 to 2025, 0.3% of the program's national total. Brown University received the most, $31.7 million.

By year

Grants under this program to recipients in Rhode Island
Fiscal yearAwardsAmount
FY 202139$15.2 million
FY 202243$14.1 million
FY 202347$11.9 million
FY 202443$12.0 million
FY 202535$13.3 million

Recipients in Rhode Island

Every recipient named in the data, fiscal 2021 to 2025
RecipientTypeAwardsAmount
Brown UniversityNonprofits36$31.7 million
The Miriam HospitalNonprofits7$13.4 million
Rhode Island HospitalNonprofits20$10.8 million
University of Rhode IslandColleges and universities7$7.0 million
Prothera Biologics, Inc.Small businesses1$2.0 million
Epivax IncSmall businesses2$1.2 million
Gordon Research ConferencesNonprofits62$486,800

Counted by the recipient's location. A recipient based in Rhode Island may carry out the work elsewhere.

Open opportunities under this program

See all 93 on the program page

Questions people ask

How much Allergy and Infectious Diseases Research money goes to Rhode Island?

$66.5 million from fiscal 2021 to 2025, across 135 awards. Rhode Island ranks 33rd of 52 states and territories for this program.

Who receives Allergy and Infectious Diseases Research money in Rhode Island?

The largest recipient is Brown University, with $31.7 million in 36 awards. Next are The Miriam Hospital and Rhode Island Hospital.

Can organizations in Rhode Island apply now?

Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.

Allergy and Infectious Diseases Research in other states

Other large programs in Rhode Island

All federal grants in Rhode Island

Amounts are federal obligations reported to USAspending.gov for fiscal 2021 to 2025; see how our data works.